Professur für Arzneimitteltherapiesicherheit und Klinische Pharmakologie

Friedrich-Alexander-Universität Erlangen-Nürnberg

Medizinische Fakultät

Einrichtungen, die nicht zum Universitätsklinikum Erlangen gehören

Institut für Experimentelle und Klinische Pharmakologie und Toxikologie

Overview

Publications

(87)

Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine (2014) Lueneburg N, Lieb W, Zeller T, Chen MH, Maas R, Carter AM, Xanthakis V, et al. Journal article Role of alanine:glyoxylate aminotransferase 2 in metabolism of asymmetric dimethylarginine in the settings of asymmetric dimethylarginine overload and bilateral nephrectomy (2014) Rodionov RN, Martens-Lobenhoffer J, Brilloff S, Hohenstein B, Jarzebska N, Jabs N, Kittel A, et al. Journal article The effect object paradigm - a means to support medication safety with clinical decision support (2014) Patapovas A, Pfistermeister B, Tarkhov A, Terfloth L, Maas R, Fromm M, Kornhuber J, et al. Journal article Implementation of warnings from Dear Doctor Letters (Rote-Hand-Briefe): an analysis of medication data from a large cohort of elderly patients (2014) Schächtele S, Tuemena T, Gassmann KG, Fromm M, Maas R Journal article Pharmacology and clinical pharmacology of methylarginines used as inhibitors of nitric oxide synthases (2014) Kittel A, Maas R Journal article Application of the Pareto principle to identify and address drug-therapy safety issues (2014) Müller F, Dormann H, Pfistermeister B, Sonst A, Patapovas A, Vogler R, Hartmann N, et al. Journal article The direct costs of adverse drug events in emergency department admissions (2012) Meier F, Maas R, Sonst A, Patapovas A, Müller F, Plank-Kiegele B, Pfistermeister B, et al. Conference contribution, Original article

‹ 1 ... 5 6 7 ›